Vaccines and Diagnostics
The Novartis Vaccines and Diagnostics Division provides more than 20 vaccines to prevent viral and bacterial diseases, as well as sophisticated instruments, assays and software to protect the blood supply from infectious diseases such as HIV and Hepatitis.
The division consists of two businesses - Novartis Vaccines and Novartis Diagnostics.
Novartis Vaccines is dedicated to delivering on the promise of prevention through the research, development and production of innovative, safe and effective vaccines. At the heart of everything we do is our commitment to preventing the spread of life-threatening diseases, protecting vulnerable populations, and keeping healthy people healthy.
By focusing on disease prevention, Novartis Vaccines plays a key role in the company's core mission: keeping people healthy, alleviating suffering and enhancing quality of life.
The current vaccine portfolio includes vaccines to prevent:
- Japanese encephalitis
- Tick-borne encephalitis
- Haemophilus Influenzae type B (Hib)
- Pertussis (whooping cough)
Novartis Diagnostics products are used to screen millions of blood donations around the world each year for pathogens such as HIV (the AIDS virus), hepatitis B and hepatitis C and West Nile virus before they are used in transfusions or other medical therapies.
Building on its strong presence in transfusion medicine, Novartis Diagnostics is also creating innovative preventive screening solutions to detect, prevent and predict disease and to improve medical outcomes.